RESEARCH TRIANGLE PARK, N.C., Jan. 9 /CNW/ -- Quintiles Transnational
Corp. today announced the expansion and consolidation of its Global Central
Laboratories and Clinical Development Services (CDS) units in Beijing to
accommodate their growing business in China.
The new consolidated Quintiles China facility, with more than 17,000
square feet of space, is located at Sun Dong Ann Plaza in Beijing, about one
block from the previous lab site in the Peking Union Medical College Hospital
(PUMCH). The new facility expands the lab space by 2,600 square feet. The
lab has 13 employees and continues to add staff. CDS occupies 10,000 square
feet of the combined office area, a major expansion over its old facility of
under 3,000 square feet. The CDS staff strength continues to grow in Beijing
and is expected to reach more than 60 people over the next 12 months.
"Quintiles' business is growing at a significant rate, and our larger
facility will allow us to efficiently accommodate both the growth and our
expanding test menu, which have moved well beyond basic safety testing to
include specialized chemistry, PCR testing and complex flow cytometry," said
Tom Wollman, Senior Vice President, Global Central Laboratories.
"We would like to thank the Peking Union Medical College Hospital for all
that it has done to help Quintiles establish and expand our Central Laboratory
in China," Wollman said. "PUMCH is one of the premier tertiary centers in
Beijing, and we will continue to foster our close working relationship with
key laboratory and scientific staff."
Lai Lee Tan, head of Clinical Operations and General Manager in China,
said the consolidation of CDS and Central Lab operations in a single facility
will improve coordination and efficiency for Quintiles' customers. "Our
clinical development business is poised for rapid acceleration in China, and
bringing our CDS and Global Labs businesses together will help our customers.
The globalization of clinical research is continuing to increase, and China is
just beginning to see the rapid growth we have experienced in India, Australia
and throughout Asia Pacific."
Quintiles' China central lab is certified by the College of American
Pathologists (CAP) and the National Glycohemoglobin Standardization Program
About Quintiles Global Central Laboratories
Quintiles Laboratories owns a network of clinically harmonized facilities
in the U.S., Europe, South Africa, China, India and Singapore, and has tightly
controlled sub-contractor laboratories in Argentina and Brazil managed by
Quintiles employees located in each of the facilities.
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With more than 19,000
employees and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at www.quintiles.com .
For further information:
For further information: Media Relations, Dick Jones, +1-919-998-2091,
firstname.lastname@example.org, or Investor Relations, Greg Connors,
+1-919-998-2000, email@example.com, both of Quintiles Transnational Corp.
Web Site: http://www.quintiles.com